Search clinical trials for: 20μg/kg SHR0410

Total 2550 results

Atridia Pty Ltd.
Linear Clinical Research

Completed

A Single Dose Study of SHR0410 in Healthy Male Participants

Acute Pain

Australia
Xiamen University
Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...

Completed

Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Cervical Cancer | Cervical Intraepithelial Neoplasia

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study of SHR4010 in Patients With Hemodialysis

Pruritus

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Trial of SHR0410 Injection in Postsurgical Pain Management

Postsurgical Pain

China
National Institute of Allergy and Infectious Diseases...
National Institutes of Health (NIH); Department of Health and Human Services

Completed

A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants

HIV Infections

United States, Zimbabwe, Kenya, South Africa
Huahui Health

Recruiting

A Study to Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus Infection

Chronic Hepatitis Delta Virus Infection

China
Atridia Pty Ltd.

Completed

A Trial of SHR0410 Injection in Hemodialysis Participants.

Pruritus

Australia
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Clinical Study of the Combination of SHR8554 Injection and SHR0410 Injection for the Treatment of Pain After Abdominal Surgery.

Pain
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Trial of SHR0410 Injection for the Treatment of Pain After Laparoscopic Surgery

Postoperative Pain Of Laparoscopic Surgery
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of SHR0410 in Hemodialysis Patients With Pruritus

Pruritus

China
Sichuan Provincial People's Hospital

Recruiting

A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in PONV

Postoperative Nausea and Vomiting

China
Intron Biotechnology, Inc.

Completed

A Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of KMRC011

Acute Radiation Syndrome

Korea, Republic of
International AIDS Vaccine Initiative
Beth Israel Deaconess Medical Center; Ragon Institute of MGH, MIT and Harvard; University of Texas Health, Houston AIDS Research Team (HART) and other collaborators

Completed

A Clinical Trial of PGDM1400 and PGT121 and VRC07-523LS Monoclonal Antibodies in HIV-infected and HIV-uninfected Adults

HIV Infections

United States
Ultragenyx Pharmaceutical Inc
Novartis; Mereo BioPharma

Completed

Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral Density

Osteoporosis | Osteopenia

United States
Huahui Health

Terminated

A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With Chronic Hepatitis B and Hepatitis D Co-infection

Chronic Hepatitis B and Hepatitis D Co-infection

China
Xiamen Amoytop Biotech Co., Ltd.

Completed

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy

Breast Cancer | Non Small Cell Lung Cancer

China
SK Bioscience Co., Ltd.
GlaxoSmithKline; Coalition for Epidemic Preparedness Innovations

Active, not recruiting

Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19)

COVID-19 (Healthy Volunteers)

Korea, Republic of
Genocea Biosciences, Inc.

Completed

Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study

Genital Herpes Simplex Type 2

United States
Butantan Institute

Active, not recruiting

Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine (Butanvac)

Coronavirus Infections | Healthy

Brazil
University of Oxford

Recruiting

A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.

Malaria,Falciparum

Burkina Faso
Oncurious NV
Beat Childhood Cancer

Completed

A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma

Relapsed or Refractory Medulloblastoma (MB), Neuroblastoma (NB), Ewing Sarcoma (ES) and Alveolar Rhabdomyosarcoma (ARMS)

United States
Genocea Biosciences, Inc.

Completed

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

Genital Herpes Simplex Type 2

United States
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vaccination

SARS-CoV-2 | COVID-19 Vaccine

China
U.S. Army Medical Research and Development Command
National Institute of Allergy and Infectious Diseases (NIAID); US Military... and other collaborators

Recruiting

Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adults (RV575)

Human Immunodeficiency Virus (HIV) | AIDS Virus

United States
Livzon Pharmaceutical Group Inc.

Active, not recruiting

Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine (COVID-19)

COVID-19 Pandemic

China
Peking University Cancer Hospital & Institute

Recruiting

To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma

Melanoma

China
Ipsen

Completed

To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)

Gastro-Enteropancreatic Neuroendocrine Tumor

United States, Austria, Denmark
SK Bioscience Co., Ltd.
Coalition for Epidemic Preparedness Innovations

Completed

Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19)

COVID-19 (Healthy Volunteers)

Korea, Republic of
Shengjing Hospital
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant Treatment

Breast Cancer

China
Green Cross Corporation

Completed

To Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome Patients

Mucopolysaccharidosis II

Korea, Republic of
Genor Biopharma Co., Ltd.

Unknown

Phase Ⅰ Clinical Study Protocol of GB223 Monoclonal Antibody Injection

Bone Tumor

China
Hangzhou Grand Biologic Pharmaceutical, Inc.
Peking Union Medical College Hospital

Unknown

Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of of HZBio1 in Healthy Subjects

Healthy Participants

China
UCB Pharma

Completed

A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer

Carcinoma | Non-Squamous Non-Small-Cell Lung Cancer

Poland, Russian Federation, Hungary
Aileron Therapeutics, Inc.

Completed

Phase 1 Safety Study of ALRN-5281 in Healthy Subjects

Growth Hormone Deficiency

United States
Imperial College London

Completed

The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) Treatment

Infertility

United Kingdom
Shandong University

Unknown

Lower Fluorescein Sodium Dose on Confocal Laser Endoscopy Image Quality and Yellow Discoloration of the Skin

Image Quality | Skin Discoloration

China
Aridis Pharmaceuticals, Inc.

Completed

Study of Single Doses of IV Aerucin in Healthy Adults

Healthy

United States
Keymed Biosciences Co.Ltd

Not yet recruiting

A Study of CM313 Injection in Subjects With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
GlaxoSmithKline

Completed

A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD Subjects (DEMAND I)

Muscular Dystrophies

France, United States
NuvOx LLC
University of Arkansas

Completed

A Phase Ib/II in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
Genor Biopharma Co., Ltd.

Recruiting

Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for Injection

HER2-positive Breast Cancer

China
Johns Hopkins University
Cultivate Biologics

Completed

The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A

Cannabis

United States
Seoul National University Hospital

Completed

Effect of Tidal Volume Change on Pressure-based Prediction of Fluid Responsiveness in Children

Plasma Volume | Tidal Volume

Korea, Republic of
Zhejiang Cancer Hospital

Recruiting

Ciprofol EC50 for Inducing Loss of Consciousness in Elderly Patients

Elderly Patients

China
Healthgen Biotechnology Corp.

Recruiting

Study of OsrhAAT or Placebo in Healthy Volunteers

Emphysema Secondary to Congenital AATD

United States
MedImmune LLC

Completed

A Phase 1 Study to Evaluate the Safety of MEDI7814 in Adult Volunteers

Healthy Subjects

United States
Sichuan Haisco Pharmaceutical Group Co., Ltd
Second Affiliated Hospital, School of Medicine, Zhejiang University

Completed

Safety, Tolerability and Pharmacokinetics of HSK21542 in Healthy Volunteers

Healthy Volunteers

China
Gangnam Severance Hospital

Completed

Remimazolam Bolus for General Anesthesia

Loss of Consciousness

Korea, Republic of
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Shanghai Public Health Clinical Center; Air Force Military Medical University... and other collaborators

Completed

Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10

Tuberculosis
Crucell Holland BV
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Assessment of CR8020, a Monoclonal Antibody Against Influenza A Viruses

Influenza

United States

Search clinical trials for: 20μg/kg SHR0410

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations